News
The high dose of Wegovy is one part of Novo Nordisk's plan to defend its obesity business, along with a major ...
According to the Financial Times, MSD – known as Merck & Co in the US and Canada – is in the final stages of a $10 billion ...
Whether stemming from early childhood adversity, combat exposure, or interpersonal abuse, trauma leaves long-term imprints on ...
Improving efficiencies and uncomplicating processes are critical to the future success of NHS Trusts across the country. The ...
Boehringer Ingelheim has raised hopes of a more patient-friendly option with the start of phase 2 testing of BI 1815368, ...
Taiho Pharmaceutical has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy ...
The second annual HLTH Europe conference brought together health leaders, start-ups, investors, and developers from across the globe for a mid-year pulse check on where healthcare innovation stands ...
A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young ...
BIO Boston: 2025 is shaping up to be a year of challenge – but also opportunity – say biotech bosses
So, what were the major themes to come out of BIO Boston 2025? Who’s getting excited about what? And – besides the obvious ...
Medistry LLC is the internet registry operator of the .med top level domain (TLD). Currently in a period of pre-registration ...
The US Senate narrowly passed President Donald Trump's tax and spending bill after weeks of horse-trading, hours of debate ...
South Korean electronics giant Samsung has continued a push into the health category with an agreement to buy Xealth, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results